RECRUITINGINTERVENTIONAL
Micronutrient and Additive Modifications May Optimize Diet To Health
About This Trial
This is a prospective clinical intervention trial where patients with moderately active ulcerative colitis are randomized to either normal healthy diet or a diet with elimination of emulsifying agents within the E 400-group with special respect to carragenan, CMC and polysorbates. At study start and end after one month their diet, clinical characteristics and microbiota will be analysed. The hypotheses are that their disease activity measured with calprotectin and their microbiota will improve after intervention.
Who May Be Eligible (Plain English)
Who May Qualify:
- Ulcerative colitis,
- Moderately active
- Stable medication
Who Should NOT Join This Trial:
- Severe disease
- Recent surgery
- Proctitis
- Pregancy
- Treatment with antibiotics
- Difficulties in understanding the information about the study
- Multimorbidity that makes it impossible to participate
Always talk to your doctor about whether this trial is right for you.
Original Eligibility Criteria
View original clinical language
Inclusion Criteria:
* Ulcerative colitis,
* Moderately active
* Stable medication
Exclusion Criteria:
* Severe disease
* Recent surgery
* Proctitis
* Pregancy
* Treatment with antibiotics
* Difficulties in understanding the information about the study
* Multimorbidity that makes it impossible to participate
Treatments Being Tested
OTHER
Normal diet
These patients will be given advice about a normal healthy diet.
DIETARY_SUPPLEMENT
E400 elimination
Patients in the intervention group will be given advice how to eliminate E440 additives with regard to carragenan, CMC and polysorbates.
Locations (1)
Region Skåne
Malmo, Skåne County, Sweden